HK1200323A1 - Anemia of cancer improving / prophylactic agent - Google Patents

Anemia of cancer improving / prophylactic agent Download PDF

Info

Publication number
HK1200323A1
HK1200323A1 HK15100724.6A HK15100724A HK1200323A1 HK 1200323 A1 HK1200323 A1 HK 1200323A1 HK 15100724 A HK15100724 A HK 15100724A HK 1200323 A1 HK1200323 A1 HK 1200323A1
Authority
HK
Hong Kong
Prior art keywords
anemia
ala
cancer
ameliorating
agent
Prior art date
Application number
HK15100724.6A
Other languages
English (en)
Chinese (zh)
Inventor
田中徹
田中彻
中島元夫
中岛元夫
安部史紀
安部史纪
河田聰史
河田聪史
高橋究
高桥究
Original Assignee
思佰益药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 思佰益药业股份有限公司 filed Critical 思佰益药业股份有限公司
Publication of HK1200323A1 publication Critical patent/HK1200323A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15100724.6A 2011-10-12 2012-10-05 Anemia of cancer improving / prophylactic agent HK1200323A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011-225383 2011-10-12
JP2011225383 2011-10-12
JP2012081346 2012-03-30
JP2012-081346 2012-03-30
PCT/JP2012/076020 WO2013054770A1 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤

Publications (1)

Publication Number Publication Date
HK1200323A1 true HK1200323A1 (en) 2015-08-07

Family

ID=48081825

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100724.6A HK1200323A1 (en) 2011-10-12 2012-10-05 Anemia of cancer improving / prophylactic agent

Country Status (7)

Country Link
US (1) US9539225B2 (OSRAM)
EP (1) EP2767280B1 (OSRAM)
JP (2) JP5881722B2 (OSRAM)
CN (1) CN103974702A (OSRAM)
HK (1) HK1200323A1 (OSRAM)
TW (1) TWI590823B (OSRAM)
WO (1) WO2013054770A1 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110339207B (zh) 2011-10-12 2022-08-05 思佰益药业股份有限公司 抗癌剂的副作用的预防剂和/或治疗剂
HK1224204A1 (en) * 2013-10-29 2017-08-18 Tokyo University Of Agriculture Frataxin enhancer
WO2018043240A1 (ja) 2016-09-02 2018-03-08 Ｓｂｉファーマ株式会社 ５－アミノレブリン酸類を含む水性製剤
JP2024006280A (ja) 2022-07-01 2024-01-17 ネオファーマジャパン株式会社 安定性に優れた非水性製剤
CN116036232A (zh) * 2023-02-09 2023-05-02 山东深海生物科技股份有限公司 一种含5-氨基乙酰丙酸或其衍生物的安神助眠药剂及制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754731B2 (ja) 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
JP5295652B2 (ja) * 2008-06-16 2013-09-18 Ｓｂｉファーマ株式会社 光障害の軽減剤
CN106692122A (zh) * 2008-10-27 2017-05-24 思佰益药业股份有限公司 以5‑氨基乙酰丙酸或其衍生物、或它们的盐作为有效成分的成人病的预防、改善剂
JP5611548B2 (ja) * 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
BR112012023780A2 (pt) * 2010-03-23 2018-07-24 Vifor (International) Ag compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
US9018257B2 (en) * 2011-03-24 2015-04-28 Bar Ilan University 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
EP2767276B1 (en) * 2011-10-12 2018-10-03 SBI Pharmaceuticals Co., Ltd. Improving / prophylactic agent for chronic kidney disease

Also Published As

Publication number Publication date
JP5881722B2 (ja) 2016-03-09
WO2013054770A1 (ja) 2013-04-18
TW201320995A (zh) 2013-06-01
JP2016033160A (ja) 2016-03-10
JPWO2013054770A1 (ja) 2015-03-30
EP2767280B1 (en) 2024-05-22
TWI590823B (zh) 2017-07-11
US20140288173A1 (en) 2014-09-25
EP2767280A1 (en) 2014-08-20
EP2767280C0 (en) 2024-05-22
US9539225B2 (en) 2017-01-10
CN103974702A (zh) 2014-08-06
EP2767280A4 (en) 2015-04-08
JP6093428B2 (ja) 2017-03-08

Similar Documents

Publication Publication Date Title
JP5881721B2 (ja) 慢性腎臓病の改善・予防剤
CN110339207B (zh) 抗癌剂的副作用的预防剂和/或治疗剂
CN104487066B (zh) 放射线损害的预防和/或治疗剂
JP6093428B2 (ja) がん性貧血改善・予防剤
CN103747784B (zh) 败血症的预防剂和/或治疗剂
CN104105482B (zh) 红细胞生成素产生促进剂
HK1202259B (en) Erythropoietin production-promoting agent
HK1194993B (en) Prophylactic agent and/or therapeutic agent for sepsis
HK1196002A (en) Anemia of cancer improving/prophylactic agent
HK1194993A (en) Prophylactic agent and/or therapeutic agent for sepsis
HK1196002B (en) Anemia of cancer improving / prophylactic agent
HK1196003B (en) Treatment agent and/or prophylactic agent for side effects of cancer drugs